Review of Direct Oral Anticoagulants and Guide for Effective Drug Utilization

被引:0
作者
Tigran Khachatryan
Christopher Hauschild
Jason Hoff
Tahmeed Contractor
Arthur Khachatryan
Huyentran Tran
Bert Matsuo
Alan Jacobson
Anthony Hilliard
机构
[1] Loma Linda University Medical Center,International Heart Institute
[2] University of Nevada,Reno School of Medicine
[3] VA Loma Linda Health Care Systems,Department of Cardiology
来源
American Journal of Cardiovascular Drugs | 2019年 / 19卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Direct oral anticoagulants (DOACs) have been developed as a viable and in some cases superior alternative to warfarin. These agents have overcome some of the limitations of warfarin, which has a narrow therapeutic window and many food and drug interactions. DOACs have been demonstrated to have a more predictable and reliable pharmacology and, unlike warfarin, do not require frequent monitoring of anticoagulant effect. For these reasons, the use of DOACs is increasing. Despite the many positive attributes of these agents, limitations and contraindications do exist. An understanding of the pharmacology, indications, and contraindications is therefore crucial for effective patient management. We review the available agents to aid in effective drug utilization.
引用
收藏
页码:525 / 539
页数:14
相关论文
共 50 条
[31]   Direct Oral Anticoagulants in Obesity: An Updated Literature Review [J].
Sebaaly, Jamielynn ;
Kelley, Denise .
ANNALS OF PHARMACOTHERAPY, 2020, 54 (11) :1144-1158
[32]   Direct oral anticoagulants: a review of common medication errors [J].
Barr, Drakeria ;
Epps, Quovadis J. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (01) :146-154
[33]   Experience with direct oral anticoagulants in pregnancy - a systematic review [J].
Areia, Ana Luisa ;
Mota-Pinto, Anabela .
JOURNAL OF PERINATAL MEDICINE, 2022, 50 (04) :457-461
[34]   Levetiracetam and direct oral anticoagulants-a systematic review [J].
Roesche, Johannes ;
Wittstock, Matthias ;
Shah, Yogesh .
CLINICAL EPILEPTOLOGY, 2025, 38 (01) :68-71
[35]   Direct Oral Anticoagulants: A Patient-centered Review [J].
Solomon, Jenna M. ;
Hume, Anne L. .
JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2016, 12 (08) :523-529
[36]   Reversal agents for direct oral anticoagulants: A focused review [J].
Arbit, Boris ;
Nishimura, Marin ;
Hsu, Jonathan C. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 :244-250
[37]   Cerebral Vein Thrombosis and Direct Oral Anticoagulants: A Review [J].
Umurungi, Johanna ;
Ferrando, Francesca ;
Cilloni, Daniela ;
Sivera, Piera .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
[38]   Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature [J].
Watras M.M. ;
Patel J.P. ;
Arya R. .
Drugs - Real World Outcomes, 2016, 3 (1) :1-6
[39]   Direct oral anticoagulants [J].
Beeton, A. .
SOUTHERN AFRICAN JOURNAL OF ANAESTHESIA AND ANALGESIA, 2023, 29 (05) :S31-S33
[40]   Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation [J].
Brais, Caroline ;
Larochelle, Josiane ;
Turgeon, Marie-Helene ;
Blais, Lucie ;
Farand, Paul ;
Perreault, Sylvie ;
Letemplier, Genevieve ;
Beauchesne, Marie-France .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2017, 20 (01) :8-14